The global demand for Transfection Reagents and Equipment Market is presumed to reach the market size of nearly USD 3.46 BN by 2028 from USD 1.79 BN in 2021 with a CAGR of 8.37% under the study period 2022 - 2028.
Transfection reagents and equipment are used in transfection, introducing genetic material, such as DNA and RNA, into eukaryotic cells to enable the cell's natural process to produce proteins. The transfection method allows the investigation of protein function, gene expression, and gene mutation. Transfection reagents have unique membrane-active properties to help the transfection complex pass through the cell's plasma and endocytic membranes.
Market Dynamics
With the increase in the elderly population and commercially available reagents, the transfection reagents and equipment market is anticipated to expand. The rising prevalence of cancer cases is expected to drive the market growth of transfection reagents and equipment. The growing demand for synthetic genes and the rise in the adoption of transfection may also foster the market growth of transfection reagents and equipment. Furthermore, the growing R&D projects funded by numerous pharmaceuticals and biotechnology organizations to develop advanced healthcare technology, the use of new biotechnology methods, and the rise in expenditure for facilities all contribute to the market growth of transfection reagents and equipment. Additionally, government initiatives for approval also aid market growth. However, the lack of awareness and the high cost of the transfection procedure may hamper the market growth of transfection reagents and equipment.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of transfection reagents and equipment. The growth and trends of transfection reagents and equipment industry provide a holistic approach to this study.
Market Segmentation
This section of the transfection reagents and equipment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By Method
- Biochemical Methods
- Physical Methods
- Viral Methods
By End User
- Pharmaceutical & Biotechnology Companies
- Academics & Research Institutes
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Transfection Reagents and Equipment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Transfection Reagents and Equipment Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the transfection reagents and equipment market include Bio-Rad Laboratories, Lonza Group, MaxCyte Inc., Merck KGaA, Mirus Bio, Polyplus-transfection SA, Promega Corporation, QIAGEN NV, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.